{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:17:14Z","timestamp":1791148634907,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biotechnology"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.jbiotec.2005.07.018","type":"journal-article","created":{"date-parts":[[2005,9,9]],"date-time":"2005-09-09T11:51:59Z","timestamp":1126266719000},"page":"261-271","source":"Crossref","is-referenced-by-count":56,"title":["Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor"],"prefix":"10.1016","volume":"121","author":[{"given":"Khaled","family":"Trabelsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Rourou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houssem","family":"Loukil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Majoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9la","family":"Kallel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbiotec.2005.07.018_bib1","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2144\/00286rr01","article-title":"Experimental design optimisation of filamentous phage transfect mammalian cells by cationic lipids","volume":"28","author":"Aujame","year":"2000","journal-title":"Biotechniques"},{"key":"10.1016\/j.jbiotec.2005.07.018_bib2","first-page":"52","article-title":"Producing human rabies vaccines at low cost","volume":"22","author":"Aycardi","year":"2002","journal-title":"Gen. Eng. News"},{"key":"10.1016\/j.jbiotec.2005.07.018_bib3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1474-4422(04)00896-8","article-title":"Preventable rabies deaths because of wrong vaccine","volume":"3","author":"Bagchi","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1097-0290(19990105)62:1<12::AID-BIT2>3.0.CO;2-G","article-title":"Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers","volume":"62","author":"Berry","year":"1999","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib5","doi-asserted-by":"crossref","first-page":"107S","DOI":"10.1042\/bst023107s","article-title":"Application of Taguchi experimental design to the optimization of baculovirus expression system","volume":"23","author":"Burch","year":"1995","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib6","series-title":"Advances Biochem. Eng.","first-page":"58","article-title":"Growth limitations in microcarrier cultures","author":"Butler","year":"1987"},{"key":"10.1016\/j.jbiotec.2005.07.018_bib7","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1093\/nar\/22.18.3801","article-title":"A simple procedure for optimisation the polymerase chain reaction (PCR) using modified Taguchi methods","volume":"22","author":"Cobb","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/vim.1990.3.243","article-title":"Production of polio vaccines: past, present and future","volume":"3","author":"Duchene","year":"1990","journal-title":"Viral Immunol."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0168-1656(97)00172-7","article-title":"Physiology of cultured animal cells","volume":"59","author":"Doverskog","year":"1997","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib10","series-title":"Culture of Animal cells","author":"Freshney","year":"1994"},{"key":"10.1016\/j.jbiotec.2005.07.018_bib11","series-title":"New Generation Vaccines","first-page":"607","article-title":"Improved vaccines against rabies","author":"Fu","year":"1997"},{"key":"10.1016\/j.jbiotec.2005.07.018_bib12","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1016\/j.vaccine.2004.12.008","article-title":"The real cost of rabies post-exposure treatments","volume":"23","author":"Goswami","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.jbiotec.2005.07.018_bib13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1023\/A:1008802331194","article-title":"Optimization of reaction variables for sucrose monoester production using lipase in solvent free system by Taguchi's method","volume":"12","author":"Han","year":"1998","journal-title":"Biotechnol. Tech."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib14","first-page":"43","article-title":"Absence of viral sequences in the WHO-Vero cell bank: a collaborative study","volume":"76","author":"Horaud","year":"1992","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0022-1759(98)00185-9","article-title":"Taguchi optimization of ELISA procedures","volume":"223","author":"Jeney","year":"1999","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jbiotec.2005.07.018_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1022437514334","article-title":"Use of Taguchi's methods as a basis to optimize hybridoma cell line growth and antibody production in a spinner flask","volume":"39","author":"Kallel","year":"2002","journal-title":"Cytotechnol."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib17","doi-asserted-by":"crossref","first-page":"22210","DOI":"10.1016\/S1201-9712(00)90114-0","article-title":"Global infectious disease surveillance","volume":"4","author":"Martinez","year":"2000","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0168-1656(02)00048-2","article-title":"Metabolic active-high density Vero cell culture on microcarriers following apoptosis prevention by galactose\/glutamine feeding","volume":"97","author":"Mendon\u00e7a","year":"2002","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib19","first-page":"1305","article-title":"Preparation of human rabies vaccine in Vero cell culture using a microcarrier system","volume":"26","author":"Mendon\u00e7a","year":"1993","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00369503","article-title":"High density Vero cell culture on microcarriers in a cell bioreactor","volume":"12","author":"Mendon\u00e7a","year":"1995","journal-title":"Bioprocess Eng."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s004490050433","article-title":"Cell metabolism and medium perfusion in Vero cell cultures on microcarriers in a bioreactor","volume":"18","author":"Mendon\u00e7a","year":"1998","journal-title":"Bioprocess Eng."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib22","series-title":"Laboratory Techniques in Rabies","first-page":"360","article-title":"General considerations in the production of brain-tissue and purified chicken embryo vaccines for human use","author":"Meslin","year":"1996"},{"key":"10.1016\/j.jbiotec.2005.07.018_bib23","first-page":"37","article-title":"Thousand liter scale microcarrier culture of Vero cells for killed polio virus vaccine","volume":"55","author":"Montagnon","year":"1984","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib24","first-page":"137","article-title":"Experience with Vero cells at Pasteur M\u00e9rieux Connaught","volume":"98","author":"Montagnon","year":"1999","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib25","first-page":"55","article-title":"The large-scale cultivation of Vero cells in microcarrier culture for virus vaccine production: preliminary studies for killed poliovirus vaccine","volume":"47","author":"Montagon","year":"1981","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1008022828736","article-title":"A microcarrier-based cell culture process for the production of a bovine respiratory syncytial virus vaccine","volume":"29","author":"Moran","year":"1999","journal-title":"Cytotechnol."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0264-410X(93)90343-V","article-title":"\u03b2-propiolactone treatment impairs the biological activity of residual DNA from BHK-21 cells infected with rabies virus","volume":"11","author":"Morgeaux","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.jbiotec.2005.07.018_bib28","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/0264-410X(94)00022-F","article-title":"An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system","volume":"13","author":"Perrin","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.jbiotec.2005.07.018_bib29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1389-1723(02)80212-2","volume":"94","author":"Prem Kumar","year":"2002","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib30","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2004.09.027","article-title":"Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administrated intradermally using the Thai Red cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals","volume":"23","author":"Quiambo","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.jbiotec.2005.07.018_bib31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/biol.2002.0345","article-title":"Development of Vero cell-derived inactivated Japanese encephalitis vaccine","volume":"30","author":"Sugawara","year":"2002","journal-title":"Biologicals"},{"key":"10.1016\/j.jbiotec.2005.07.018_bib32","series-title":"Laboratory Techniques in Rabies","first-page":"354","article-title":"A rapid tissue culture test for determining rabies neutralizing antibody","author":"Smith","year":"1973"},{"key":"10.1016\/j.jbiotec.2005.07.018_bib33","series-title":"Introduction to quality engineering","author":"Taguchi","year":"1986"},{"key":"10.1016\/j.jbiotec.2005.07.018_bib34","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.enzmictec.2004.11.008","article-title":"Comparison of various culture modes for the production of rabies virus by Vero cells grown on microcarriers in a 2-l bioreactor","volume":"36","author":"Trabelsi","year":"2005","journal-title":"Enzyme Microb. Technol."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib35","first-page":"153","article-title":"Qualification of working cell banks for the Vero cell line to produce licensed human vaccines","volume":"70","author":"Vincent-Falquet","year":"1989","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0168-1656(92)90132-S","article-title":"Safety and economic aspects of continuous mammalian cell culture","volume":"22","author":"Werner","year":"1992","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib37","series-title":"Laboratory Techniques in Rabies","first-page":"360","article-title":"The NIH test for potency","author":"Wilbur","year":"1996"},{"key":"10.1016\/j.jbiotec.2005.07.018_bib38","unstructured":"Wiktor, T.J., Fanget, B.J., Fournier, P., Montagnon, B.J., 1987. Process for the large scale production of rabies vaccine. US Patent No. 4,664,912."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib39","series-title":"WHO Technical Report Series, vol. 878","article-title":"Requirements for the use of animal cells as in vitro substrates for the production of biologicals","year":"1998"},{"key":"10.1016\/j.jbiotec.2005.07.018_bib40","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/bit.10917","article-title":"Rabies virus production in high Vero cell density cultures on macroporous microcarriers","volume":"85","author":"Yokomizo","year":"2004","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jbiotec.2005.07.018_bib41","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1016\/S0264-410X(02)00260-8","article-title":"Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine","volume":"20","author":"Yusibov","year":"2002","journal-title":"Vaccine"}],"container-title":["Journal of Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016816560500430X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016816560500430X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T11:07:44Z","timestamp":1553080064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016816560500430X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S016816560500430X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbiotec.2005.07.018","relation":{},"ISSN":["0168-1656"],"issn-type":[{"value":"0168-1656","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}